• Family risk Patients with colorectal cancer do not understand that their family members are at an increased risk for developing colorectal cancer themselves
• Race and colorectal cancer African American colorectal cancer patients have inaccurate perceptions of the increased risk of their first degree relatives
• Written reports A computer-generated endoscopy report significantly improves patient recall of endoscopic procedure information compared to a verbal report alone
• Measurements in colonoscopy and virtual colonoscopy Colonoscopy measurements have a high correlation to virtual colonoscopy centerline measurements
• EZ Detect This pilot study suggests the new colorectal cancer screening kit "EZ Detect" is sensitive and well-tolerated by patients
• Adherence to flexible sigmoidoscopy and colonoscopy Patients referred by a gastroenterologist have a higher adherence than patients referred by a non-gastroenterologist

• Predictive value of low-grade and indefinite dysplasia in ulcerative colitis Low-grade and indefinite dysplasia predict unique timelines for progression to higher grade neoplasia
• 5-ASA and chemoprevention 5-ASA medications can reduce the risk of colorectal neoplasia in patients with ulcerative colitis
• Survey of patient interest in IBD genetics Most IBD patients are interested in IBD testing
• Visibility of neoplasia in patients with ulcerative colitis Most neoplasia is endoscopically visible in patients with ulcerative colitis
• Peri-appendiceal red patch Confirmation of the peri-appendiceal red patch in patients with ulcerative colitis
• p53 in IBD p53 mutations in Crohn's disease patients are associated with dysplasia
• Infliximab and pulmonary eosiniphilia Case report: Infliximab transfusion may be associated with pulmonary eosinophilia
• 5-ASA therapy and the risk of colorectal cancer in patients with IBD 5-ASA therapies in the year prior to a CRC diagnosis are not associated with a reduced risk of CRC among IBD patients
• 5-ASA therapy and the risk of colorectal polyps in patients with IBD Mesalamine reduces the risk for polyps in some patients with IBD
• Challenges in genetic testing and counseling of IBD Appropriate education and counseling is required to incorporate advancements in our understanding of IBD into clinical genetic testing
• The gastroenterologist-pathologist partnership The imporatnce of cooperation between gastroenterologist and pathologist for patients with IBD
• When an IBD patient refuses therapy A medical and ethical review of what to do when a patient refuses therapy
• Mucosal healing in ASCEND trials Endoscopically Measured Mucosal Healing Correlated with Response to Therapy in Moderately Active UC
• Leukemic colitis Case report of a patient with a past medical history of chronic myelomonocytic leukemia
• Cerebral venous sinus thrombosis Two cases of cerebral venous sinus thrombosis complicating inflammatory bowel disease